Changzhou Qianhong Biopharma Co Ltd002550
▼ NegativeCapitalrelevance
Net profit fell 40.78% and revenue declined 12% in H1 2026.

Qianhong Pharmaceutical released its 2026 semi-annual report, achieving operating revenue of 758 million yuan, down 12% year-on-year. Net profit attributable to shareholders of the listed company was 153 million yuan, down 40.78% year-on-year. The company's second-quarter net profit was 68 million yuan, down 20% quarter-on-quarter from 85 million yuan in the first quarter.
Changzhou Qianhong Biopharma Co LtdNet profit fell 40.78% and revenue declined 12% in H1 2026.